Cargando…
Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
Chikungunya virus (CHIKV) is an alphavirus that has spread globally in the last twenty years. Although mortality is rather low, infection can result in debilitating arthralgia that can persist for years. Unfortunately, no treatments or preventive vaccines are currently licensed against CHIKV infecti...
Autores principales: | Schmidt, Christin, Schnierle, Barbara S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580835/ https://www.ncbi.nlm.nih.gov/pubmed/36277603 http://dx.doi.org/10.2147/DDDT.S366112 |
Ejemplares similares
-
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
por: Schmidt, Christin, et al.
Publicado: (2023) -
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections
por: Schmidt, Christin, et al.
Publicado: (2022) -
A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses
por: Schmidt, Christin, et al.
Publicado: (2022) -
Cellular Attachment and Entry Factors for Chikungunya Virus
por: Schnierle, Barbara S.
Publicado: (2019) -
COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
por: Wang, Shen, et al.
Publicado: (2021)